T3	Subject 10 87	a 31-year-old women with recurrent Hodgkin's lymphoma and unrecognized HMSN-1
T5	Effect 102 125	severe motor neuropathy
T6	Treatment 126 198	3 weeks after the first cycle of treatment including 2 mg of vincristine
T7	Age 12 23	31-year-old
T8	Gender 24 29	women
T9	Treat-Disorder 35 63	recurrent Hodgkin's lymphoma
T10	Severity_cue 102 108	severe
T11	Time_elapsed 126 133	3 weeks
T12	Dosage 179 183	2 mg
T13	Drug 187 198	vincristine
T4	Adverse_event 92 101	developed
E1	Adverse_event:T4 
A1	Severity E1 High
T1	Sub-Disorder 68 87	unrecognized HMSN-1
